Respuesta a "Paricalcitol en la enfermedad renal crónica en etapas anteriores a la diálisis"
Response to ¿Paricalcitol for pre-dialysis stages of chronic kidney disease¿
Leído
9976
Vecesse ha leído el artículo
2591
Total PDF
7385
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 20 | 10 | 30 |
| 2025 6 | 135 | 165 | 300 |
| 2025 5 | 63 | 27 | 90 |
| 2025 4 | 49 | 25 | 74 |
| 2025 3 | 83 | 52 | 135 |
| 2025 2 | 59 | 27 | 86 |
| 2025 1 | 53 | 41 | 94 |
| 2024 12 | 37 | 28 | 65 |
| 2024 11 | 38 | 40 | 78 |
| 2024 10 | 38 | 25 | 63 |
| 2024 9 | 39 | 18 | 57 |
| 2024 8 | 44 | 39 | 83 |
| 2024 7 | 53 | 24 | 77 |
| 2024 6 | 45 | 33 | 78 |
| 2024 5 | 71 | 29 | 100 |
| 2024 4 | 48 | 34 | 82 |
| 2024 3 | 33 | 26 | 59 |
| 2024 2 | 28 | 29 | 57 |
| 2024 1 | 32 | 25 | 57 |
| 2023 12 | 26 | 24 | 50 |
| 2023 11 | 20 | 27 | 47 |
| 2023 10 | 34 | 29 | 63 |
| 2023 9 | 30 | 31 | 61 |
| 2023 8 | 28 | 21 | 49 |
| 2023 7 | 32 | 24 | 56 |
| 2023 6 | 50 | 18 | 68 |
| 2023 5 | 34 | 31 | 65 |
| 2023 4 | 16 | 22 | 38 |
| 2023 3 | 35 | 28 | 63 |
| 2023 2 | 20 | 22 | 42 |
| 2022 1 | 29 | 26 | 55 |
| 2022 12 | 26 | 35 | 61 |
| 2022 11 | 40 | 28 | 68 |
| 2022 10 | 42 | 37 | 79 |
| 2022 9 | 23 | 28 | 51 |
| 2022 8 | 36 | 42 | 78 |
| 2022 7 | 40 | 53 | 93 |
| 2022 6 | 21 | 23 | 44 |
| 2022 5 | 31 | 30 | 61 |
| 2022 4 | 42 | 57 | 99 |
| 2022 3 | 34 | 44 | 78 |
| 2022 2 | 34 | 45 | 79 |
| 2021 1 | 27 | 35 | 62 |
| 2021 12 | 26 | 37 | 63 |
| 2021 11 | 25 | 49 | 74 |
| 2021 10 | 25 | 48 | 73 |
| 2021 9 | 37 | 37 | 74 |
| 2021 8 | 23 | 38 | 61 |
| 2021 7 | 20 | 27 | 47 |
| 2021 6 | 29 | 17 | 46 |
| 2021 5 | 22 | 25 | 47 |
| 2021 4 | 74 | 34 | 108 |
| 2021 3 | 22 | 24 | 46 |
| 2021 2 | 28 | 18 | 46 |
| 2020 1 | 25 | 14 | 39 |
| 2020 12 | 15 | 15 | 30 |
| 2020 11 | 23 | 15 | 38 |
| 2020 10 | 24 | 11 | 35 |
| 2020 9 | 20 | 3 | 23 |
| 2020 8 | 34 | 15 | 49 |
| 2020 7 | 15 | 7 | 22 |
| 2020 6 | 21 | 14 | 35 |
| 2020 5 | 25 | 9 | 34 |
| 2020 4 | 18 | 12 | 30 |
| 2020 3 | 28 | 11 | 39 |
| 2020 2 | 37 | 25 | 62 |
| 2020 1 | 30 | 23 | 53 |
| 2019 12 | 32 | 13 | 45 |
| 2019 11 | 21 | 10 | 31 |
| 2019 10 | 30 | 14 | 44 |
| 2019 9 | 31 | 30 | 61 |
| 2019 8 | 26 | 16 | 42 |
| 2019 7 | 18 | 18 | 36 |
| 2019 6 | 21 | 15 | 36 |
| 2019 5 | 29 | 21 | 50 |
| 2019 4 | 54 | 24 | 78 |
| 2019 3 | 28 | 27 | 55 |
| 2019 2 | 25 | 21 | 46 |
| 2019 1 | 19 | 17 | 36 |
| 2018 12 | 53 | 36 | 89 |
| 2018 11 | 59 | 16 | 75 |
| 2018 10 | 51 | 12 | 63 |
| 2018 9 | 43 | 13 | 56 |
| 2018 8 | 47 | 16 | 63 |
| 2018 7 | 36 | 11 | 47 |
| 2018 6 | 41 | 12 | 53 |
| 2018 5 | 41 | 15 | 56 |
| 2018 4 | 48 | 11 | 59 |
| 2018 3 | 50 | 15 | 65 |
| 2018 2 | 43 | 11 | 54 |
| 2018 1 | 33 | 7 | 40 |
| 2017 12 | 41 | 10 | 51 |
| 2017 11 | 41 | 17 | 58 |
| 2017 10 | 33 | 12 | 45 |
| 2017 9 | 28 | 11 | 39 |
| 2017 8 | 25 | 9 | 34 |
| 2017 7 | 32 | 12 | 44 |
| 2017 6 | 34 | 18 | 52 |
| 2017 5 | 37 | 11 | 48 |
| 2017 4 | 25 | 19 | 44 |
| 2017 3 | 30 | 13 | 43 |
| 2017 2 | 16 | 9 | 25 |
| 2016 1 | 20 | 9 | 29 |
| 2016 12 | 46 | 12 | 58 |
| 2016 11 | 59 | 14 | 73 |
| 2016 10 | 70 | 9 | 79 |
| 2016 9 | 115 | 4 | 119 |
| 2016 8 | 185 | 5 | 190 |
| 2016 7 | 202 | 11 | 213 |
| 2016 6 | 107 | 0 | 107 |
| 2016 5 | 124 | 0 | 124 |
| 2016 4 | 98 | 0 | 98 |
| 2016 3 | 104 | 0 | 104 |
| 2016 2 | 140 | 0 | 140 |
| 2015 1 | 141 | 0 | 141 |
| 2015 12 | 139 | 0 | 139 |
| 2015 11 | 111 | 0 | 111 |
| 2015 10 | 81 | 0 | 81 |
| 2015 9 | 76 | 0 | 76 |
| 2015 8 | 90 | 0 | 90 |
| 2015 7 | 73 | 0 | 73 |
| 2015 6 | 38 | 0 | 38 |
| 2015 5 | 51 | 0 | 51 |
| 2015 4 | 23 | 0 | 23 |
| 2015 2 | 1707 | 0 | 1707 |
Mostrar todo
